Non-viral and hybrid vectors in human gene therapy: an update

被引：172

作者：

Schmidt-Wolf, GD ^{[1
]}

Schmidt-Wolf, IGH ^{[1
]}

机构：

[1] Univ Bonn, Med Klin & Poliklin 1, D-5300 Bonn, Germany

来源：

TRENDS IN MOLECULAR MEDICINE | 2003年 / 9卷 / 02期

关键词：

D O I：

10.1016/S1471-4914(03)00005-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Non-viral DNA vectors have several advantages over viral vectors. For example, virus production is expensive and there are safety concerns regarding viral manipulations. In addition, the size of the delivered plasmid is limited by the size of the viral capsid, whereas this is not a problem with non-viral vectors. The major disadvantage of using non-viral DNA delivery vectors, compared with their viral counterparts, is the low transfection efficiency. This has resulted in low levels of usage in clinical trials. Consequently, the majority of research into non-viral gene therapy has been focused on developing more efficient vectors.

引用

页码：67 / 72

页数：6

共 50 条

[1] In vivo characteristics of cationic liposomes as delivery vectors for gene therapy [J].

Audouy, SAL ;

de Leij, LFMH ;

Hoekstra, D ;

Molema, G .

PHARMACEUTICAL RESEARCH, 2002, 19 (11) :1599-1605

[2] Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse [J].

Bachy, M ;

Boudet, F ;

Bureau, M ;

Girerd-Chambaz, Y ;

Wils, P ;

Scherman, D ;

Meric, C .

VACCINE, 2001, 19 (13-14) :1688-1693

[3] Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene [J].

Blezinger, P ;

Wang, JJ ;

Gondo, M ;

Quezada, A ;

Mehrens, D ;

French, M ;

Singhal, A ;

Sullivan, S ;

Rolland, A ;

Ralston, R ;

Min, W .

NATURE BIOTECHNOLOGY, 1999, 17 (04) :343-348

[4] Gene therapy of lymphoma [J].

Buttgereit, P ;

Schmidt-Wolf, IGH .

JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (03) :457-467

[5] Prediction and optimization of gene transfection and drug delivery by electroporation [J].

Canatella, PJ ;

Prausnitz, MR .

GENE THERAPY, 2001, 8 (19) :1464-1469

[6] Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors [J].

Carlisle, RC ;

Bettinger, T ;

Ogris, M ;

Hale, S ;

Mautner, V ;

Seymour, LW .

MOLECULAR THERAPY, 2001, 4 (05) :473-483

[7] ADENOVIRUS ENHANCEMENT OF TRANSFERRIN POLYLYSINE-MEDIATED GENE DELIVERY [J].

CURIEL, DT ;

AGARWAL, S ;

WAGNER, E ;

COTTEN, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8850-8854

[8] Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound [J].

Endoh, M ;

Koibuchi, N ;

Sato, M ;

Morishita, R ;

Kanzaki, T ;

Murata, Y ;

Kaneda, Y .

MOLECULAR THERAPY, 2002, 5 (05) :501-508

[9] Nomenclature for synthetic gene delivery systems [J].

Felgner, PL ;

Barenholz, Y ;

Behr, JP ;

Cheng, SH ;

Cullis, P ;

Huang, L ;

Jessee, JA ;

Seymour, L ;

Szoka, F ;

Thierry, AR ;

Wagner, E ;

Wu, G .

HUMAN GENE THERAPY, 1997, 8 (05) :511-512

[10]

Fenske DB, 2002, METHOD ENZYMOL, V346, P36

← 1 2 3 4 5 →